The independent, non-profit HealthWell Foundation is launching a new fund dedicated to supporting patients who suffer from…
Articles by Patrícia Silva, PhD
A phase III clinical trial sponsored by the Fundación Pública Andaluza para la gestión de la Investigación en…
Dr. Thomas Kuerner at Nippon Boehringer Ingelheim Co., Ltd. in Japan published a review regarding the…
Researchers from Shanghai Jiao Tong University in China published in the journal BioMed…
The University of Alabama at Birmingham recently reacted to news of its inclusion into the Pulmonary Fibrosis Foundation Care…
The European Commission (EC) has approved Boehringer Ingelheim‘s application for the commercialization of the drug nintedanib,…
Lung Institute has announced the opening of a new clinic located in Scottsdale, Arizona this February, according to a…
Columbia University Medical Center and Biogen Idec have established a strategic alliance worth $30 million focused on genetic research with…
Genkyotex, a company developing selective NOX inhibitors for the treatment of chronic diseases, has completed a $21 million Series D round…
Biopharmaceutical Bristol-Myers Squibb Company and the non-profit organization California Institute for Biomedical Research (Calibr) have established a worldwide research…